Alerts will be sent to your verified email
Verify Email
MONOPHARMA
|
Mono Pharmacare
|
Ushdev International
|
Shrenik
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
7.94 % | 0.55 % | 24.55 % |
|
5yr average Equity Multiplier
|
3.7 | -0.04 | 3.94 |
|
5yr Average Asset Turnover Ratio
|
1.16 | 0.12 | 3.31 |
|
5yr Avg Net Profit Margin
|
2.14 % | -131.68 % | -141.96 % |
|
Price to Book
|
1.09 | 0.0 | 0.0 |
|
P/E
|
10.86 | 0.0 | 207.78 |
|
5yr Avg Cash Conversion Cycle
|
151.42 Days | 135.38 Days | 597.73 Days |
|
Inventory Days
|
219.92 Days | 0.0 | 499.59 Days |
|
Days Receivable
|
79.66 Days | 135.38 Days | 726.73 Days |
|
Days Payable
|
54.73 Days | 0.0 | 210.32 Days |
|
5yr Average Interest Coverage Ratio
|
2.12 | -145.66 | -103.06 |
|
5yr Avg ROCE
|
11.4 % | 0.55 % | 37.56 % |
|
5yr Avg Operating Profit Margin
|
5.11 % | -213.28 % | -175.69 % |
|
5 yr average Debt to Equity
|
2.07 | -0.79 | 1.96 |
|
5yr CAGR Net Profit
|
34.58 % | n/a | n/a |
|
5yr Average Return on Assets
|
2.31 % | -14.56 % | -1761.36 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
56.72 % | 40.7 % | 25.38 % |
|
Share Pledged by Promoters
|
0.0 | 37.98 % | 99.94 % |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -0.11 % | -20.72 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Mono Pharmacare
|
Ushdev International
|
Shrenik
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
Product Wise Break-Up
|